Revolution Medicines’ $345 Million Common Stock Public Offering

Pietro Martinoia
Tagged:

Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved.Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the pricing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now